Products
Platform
Research
Market
Learn
Partner
Support
IPO

A

Apollo Hospitals Enterprise Share Price

7012.5
+94.00 (1.36%)
APOLLOHOSP • 19 Dec, 2025 | 03:29 PM
Buywith MTF at 5x leverage

1Y Annualised Return

-5.19%

3Y Annualised Return

14.62%

5Y Annualised Return

24.29%

10Y Annualised Return

16.92%

The current prices are delayed, login or Open Demat Account for live prices.

Apollo Hospitals Enterprise Stock Performance

1W Return-1.25
1Y Return-3.91
Today's Low6902
Prev. Close6,918.50
Mkt Cap (Cr.)1,00,828.99
1M Return-5.99
3Y Return52.10
52-Week High8099.5
Open6,919.00
PE Ratio71.95
6M Return0.04
Today's High7024
52-Week Low6001
Face Value5

Apollo Hospitals Enterprise Company background

Founded in: 1979
Managing director: Suneeta Reddy

Founded in: 1979 Managing director: Suneeta Reddy

Apollo Hospitals Enterprise Limited (AHEL) is a very well-known name in private healthcare in Asia. They're renowned for setting high standards in healthcare. But hospitals are not all they do. Apollo also has their hands in pharmacies, primary care clinics, and diagnostic services.

Apollo's adventure started on December 5, 1979. That’s when they opened their very first 250-bed hospital in Chennai, India. The goal? To provide specialty and super-specialty medical services like Indians had never seen before. 1985, and they were already expanding with 46 more beds, actually establishing themselves as a major player in the healthcare game.

Through the years, Apollo Hospitals has been sort of a pioneer in transforming the Indian healthcare scene. One of their big moves was introducing corporate healthcare delivery. Now why’s that important? It helped make high-quality healthcare more accessible and affordable for a lot more folks.

Expanding Facilities and Innovations in Healthcare

Back in 1986, Apollo Hospitals launched the Apollo Health Association (AHA) to introduce some fresh health insurance options. Do note that this was actually a game-changer—it gave people access to world-class healthcare across 76 top hospitals in select cities, making high-quality medical care more affordable.

In the late 80s, and Apollo was leading the charge in healthcare tech. In 1989, they were the first to bring Magnetic Resonance Imaging (MRI) to India, revolutionizing medical diagnostics. They didn’t stop there; they also rolled out some cutting-edge tech like the SOMATOMCR CT scanner, breast-scanning tools, and video endoscopy, which helped catch serious conditions like carcinoma early.

Same year Apollo teamed up with the USSR's I.R.T.C. of Eye Microsurgery to open the Apollo Fyodorov Eye Research Institute. They dived into advanced research and treatments in eye care. But, there's more! In 1991, they launched the Apollo School of Nursing to offer nurses top-tier training and set them up for successful careers.

Expansion and Internationalization

Apollo Hospitals didn't just grow quietly; they kept adding new departments focusing on specialized health services. Back in 1993, they opened a cancer hospital with 150 beds, putting a big emphasis on cutting-edge care and research. It was a big step forward for them.

Then, in 1995, and they opened another cancer hospital, this time in Hyderabad. That was a really big deal for them and a key moment in their growth story.

By the time 1998 rolled around, Apollo Hospitals decided to take a bold step onto the international stage. They teamed up with the Sri Lankan government and opened a super-specialty hospital in Colombo. Do note that this move marked the beginning of Apollo’s adventure into the world market.

Strategic Partnerships

Teaming up with others has been key to Apollo's success. 1997 they joined forces with Jardine, a company from the UK, to bring Health Maintenance Organizations (HMOs) to India. This move was all about matching up with international healthcare standards.

Then, in 2001, Apollo struck another important partnership, this time with the government of Mauritius. This collaboration helped them become a top healthcare provider for the people there. Through these partnerships, Apollo Hospitals have been able to keep up with the latest in healthcare innovations and spread their wings globally.

Technology Integration and Innovations

In 2004, Apollo Hospitals took a big step by teaming up with the Defence Research and Development Organisation (DRDO). They combined their strengths to boost the hospital’s technology. This partnership brought about some cutting-edge medical services, like the Apollo National Heart Plan, which is a full health program that focuses on everything from prevention to disease management and treatment.

By 2005, Apollo had significantly upgraded its technological setup. Did you know that their hospital in Delhi earned the prestigious Joint Commission International (JCI) certification? Note that it is a big deal because it recognizes excellence in quality care and safety.

Diversification into Health Insurance and New Ventures

As part of upping its game, Apollo Hospitals jumped into the health insurance market. In 2006, they joined forces with Deutsche Krankenversicherung AG (DKV) so as to form a joint venture focused on health insurance. Do note that this move was all about boosting their healthcare services and offering a more complete package for patient care.

Then Apollo went big on research too. In 2009, they opened a clinical trial facility in Hyderabad, joining hands with Quintiles Mauritius Holdings Inc. so as to conduct Phase I clinical trials. This was a major step forward in showing their dedication to medical research and innovation.

Plus, they poured resources into new facilities like the Apollo Health City in Hyderabad. This enormous 33-acre site offers all sorts of integrated healthcare services, from prevention and management to wellness and research.

Growth in the Retail Pharmacy Sector

Apollo Hospitals Enterprise has made great progress in the retail pharmacy industry. In 2014, they expanded their market presence by acquiring 320 pharmacy stores from Hetero Med Solutions Limited. This expansion was a big step, increasing their reach in regions like Telangana, Andhra Pradesh, and Tamil Nadu. This strategic move allowed Apollo to improve their operational efficiency and achieve economies of scale, leading to increased profitability and a wider market reach.

2022, and Apollo made another smart move by transferring its pharmacy distribution and the Apollo 24/7 digital healthcare platform to Apollo HealthCo Limited, a wholly-owned subsidiary. This transaction, worth Rs 12,100 million, aligns with Apollo's strategy to concentrate on core healthcare services while giving them a strong foothold in the booming digital healthcare market.

International Expansion and Global Partnerships

Apollo Hospitals Enterprise has been making big moves to go global. One of their standout projects was joining forces with the Hainan Ecological Smart City Group (HESCG) in China so as to set up a cutting-edge hospital in Hainan Province. This partnership is all about bringing Apollo’s expertise in hospital management and medical services to China's booming healthcare scene.

Apollo is keen to connect with international financial bodies and healthcare partners. For example, in December 2016, they landed a huge equity investment of Rs 450 crore from the International Finance Corporation (IFC). This deal gave IFC a 29.03% stake in Apollo Health and Lifestyle Limited (AHLL), a company fully owned by Apollo. This investment was a game-changer, helping AHLL spread its wings and grow its retail healthcare services, which include primary health clinics, day surgery centers, and birthing centers.

Financial Performance and Strategic Investments

Apollo Hospitals has been doing well financially over the years, thanks to its expanding network of hospitals, retail pharmacies, and healthcare services. The Apollo Hospitals Enterprise share price has mirrored this success. In a notable financial move in 2021, Apollo Hospitals raised a significant amount of money through a Qualified Institutional Placement (QIP). By issuing 4.66 million shares at Rs 2511 each, they pulled in about Rs 1,170 crore.

In addition to raising capital, Apollo has fine-tuned its finances by selling off non-core assets. Back in 2016, for instance, they sold their 23.3% stake in Apollo Munich Health Insurance to Munich Re for Rs 163.5 crore. By shedding these non-central assets, Apollo has been able to concentrate more on their primary healthcare services while extracting value from peripheral parts of the business. Their strategy of focusing on core healthcare operations while smartly managing acquisitions, expansions, and divestments keeps them poised for long-term success.

Apollo Hospitals Enterprise Financial Highlights


For the full year FY2025–2026, revenue reached ₹21994.3 crore and profit touched at ₹1472.1 crore. As of Sep '25, Apollo Hospitals Enterprise’s market capitalisation stood at ₹1,00,828.99 crores. Shareholding as of Sep '25 shows promoters holding 28%, with FIIs at 44.2%, DIIs at 21.4%, and public at 6.4%.

Apollo Hospitals Enterprise Share Price Today


As of 22 Dec 2025, Apollo Hospitals Enterprise share price is ₹7012.5. The stock opened at ₹6919 and had closed at ₹6918.5 the previous day. During today’s trading session, Apollo Hospitals Enterprise share price moved between ₹6,902.00 and ₹7,024.00, with an average price for the day of ₹6963.00. Over the last 52 weeks, the stock has recorded a low of ₹6,001.00 and a high of ₹8,099.50. In terms of performance, Apollo Hospitals Enterprise share price has declined by 0.7% over the past six months and has declined by 5.19% over the last year.
Read More
Apollo Hospitals Enterprise SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 5 years with a gain of 0 (+0.00%)
View details of Market Depth

Apollo Hospitals Enterprise Fundamental

Market Cap (in crs)

1,00,828.99

Face Value

5

Turnover (in lacs)

16,531.41

Key Metrics

Qtr Change %
-10.2
Dividend yield 1yr %
Above industry Median
0.3

Apollo Hospitals Enterprise Key Financials

View more
Loading chart...
Apollo Hospitals Enterprise Quarterly Revenue
Apollo Hospitals Enterprise Yearly Revenue
Apollo Hospitals Enterprise Quarterly Net Profit/Loss
Apollo Hospitals Enterprise Yearly Net Profit/Loss

Apollo Hospitals Enterprise Result Highlights

  • Apollo Hospitals Enterprise Ltd reported a 8.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 13.0%.

  • Its expenses for the quarter were up by 7.1% QoQ and 12.1% YoY.

  • The net profit increased 12.0% QoQ and increased 24.8% YoY.

  • The earnings per share (EPS) of Apollo Hospitals Enterprise Ltd stood at 33.19 during Q2 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Apollo Hospitals Enterprise Shareholding Pattern

Promoter
28%
Foreign Institutions
44.2%
Mutual Funds
16.5%
Domestic Institutions
21.4%
Public
6.4%

Apollo Hospitals Enterprise Technical Analysis

Moving Averages Analysis
7012.5
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
Day EMA5
6,996.20
Day EMA10
7,044.60
Day EMA12
7,065.90
Day EMA20
7,150.50
Day EMA26
7,207.00
Day EMA50
7,352.20
Day EMA100
7,407.50
Day EMA200
7,282.20
Delivery & Volume
Loading chart...

Day

65.60%

Week

65.30%

Month

67.00%

Delivery & Volume

6,979.50
Pivot
Resistance
First Resistance
7,057
Second Resistance
7,101.50
Third Resistance
7,179
Support
First Support
6,935
Second support
6,857.50
Third Support
6,813
Relative Strength Index
34.89
Money Flow Index
20.21
MACD
-141.04
MACD Signal
-137.59
Average True Range
109.18
Average Directional Index
50.33
Rate of Change (21)
-5.53
Rate of Change (125)
-0.72
Compare

Apollo Hospitals Enterprise Latest News

24 NOV 2025 | Monday
13 NOV 2025 | Thursday
08 NOV 2025 | Saturday

Please be aware that Apollo Hospitals Enterprise stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account